Abdullah Kutlar is an Oncology physician affiliated with Augusta University. OpenAlex indexes 417 publications with 14,384 citations (h-index 53); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 15th St
Augusta, GA 309120004
Telephone
706-721-2505Registry record last updated 4 Apr 2011.
Clinical trials
- The Role of Endothelin-1 in Sickle Cell Disease
Sponsor: Augusta University
- Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Sponsor: Abdullah Kutlar
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments$13,767openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20256 payments$10,000openpaymentsdata.cms.gov ↗
- Genetix Biotherapeutics IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2001–2025 per NIH RePORTER. The latest:
- Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
Augusta University
FY2025$750,712R33HL162681 - Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
Augusta University
FY2024$743,146R33HL162681 - Phase I study of panobinostat in adults with sickle cell disease: novel approach to recruitment and retention
Augusta University
FY2023$782,126R33HL162681
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
New England Journal of Medicine
2024 - Pregnancy outcomes with hydroxyurea use in women with sickle cell disease
American Journal of Hematology
2022 - Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
American Journal of Hematology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Avirup Guha, MBBS
Augusta University
Neal Weintraub, MD
Augusta University
Askiel Bruno, MD
Augusta University
David Terris, MD
Augusta University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”